Clinical Trial Update: Comparison of Atomoxetine and Placebo in Children With Attention-Deficit/Hyperactivity Disorder (ADHD) and/or Reading Disorder (RD) [Phase 4]

View source ↗

Summary

A Phase 4 trial compared atomoxetine to placebo in children with ADHD and/or reading disorder; results were posted in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder
• Reading Disorder

Drugs mentioned

• STRATTERA (Atomoxetine hydrochloride)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Attention Deficit Hyperactivity Disorder, Reading Disorder | Phase 4 | Status: COMPLETED | Results posted: 2010-04-06